share_log

康方生物-B:自願公告 - 依沃西(PD-1 /VEGF,AK112)近期獲中國國家藥監局藥品審評中心(CDE)授予三項突破性療法認定

AKESO, INC. - B: VOLUNTARY ANNOUNCEMENT - IVONESCIMAB(PD-1/VEGF, AK112) WAS GRANTED THREE BREAKTHROUGH THERAPY DESIGNATIONS BY CENTER FOR DRUG EVALUATION(CDE) OF THE NMPA

Nov 13, 2022 19:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more